Facebook
X
LinkedIn
Forward2026 California Head and Neck Cancer Consortium
2026 California Head and Neck Cancer Consortium Overview
The California consortium is an interdisciplinary collaborative focused on best of class diagnosis, treatment, and survivorship for head and neck cancer patients. Despite advances in diagnostics, treatment modalities, and multidisciplinary care, significant gaps remain in the current management of head and neck cancers. These gaps contribute to variability in clinical practice, delays in diagnosis, suboptimal treatment planning, and inconsistent incorporation of supportive care and survivorship strategies. Current practice consists of variability in diagnostic approaches and staging accuracy, fragmented or delayed multidisciplinary coordination, and the inconsistent or late engagement of supportive care services. Ideal practice includes standardized use of guideline-based diagnostic pathways and accurate/consistent staging, seamless and timely collaboration among all relevant specialties through integrated tumor boards and care pathways, and early integration of speech-language pathology, nutrition, dental care, and survivorship support.
Multidisciplinary care is essential but unevenly implemented, and there is variation in training and clinical exposure, and supportive and rehabilitative services are underutilized. This activity is designed to translate learning into demonstrable changes in real-world practice with measurable improvements. Such improvements include increased adherence to evidence-based guidelines, improved multidisciplinary coordination, earlier integration of supportive services, reduction in unwarranted practice variation, greater use of validated quality measures, as well as better functional outcomes (speech, swallowing, nutrition). By aligning education with measurable outcomes, the consortium aims to drive meaningful, sustainable improvements in head and neck cancer care. As such, it is imperative that clinicians remain current with rapidly evolving evidence in order to support consistent guideline-based practice, improve coordination across the care continuum, and enhance patient outcomes and quality of care. The field is advancing faster than routine clinical workflows can adapt. With diverse perspectives and expertise, we come together to share ideas and work toward advancing the field and creating meaningful impact in our fight against head and neck cancer.
Target Audience
Healthcare professionals involved in the diagnosis, treatment, and multidisciplinary management of head and neck cancers, including otolaryngologists, head and neck surgeons, radiation oncologists, medical oncologists, radiologists, pathologists, primary care providers, advanced practice providers, nurses, and allied health professionals who participate in the care of patients with complex head and neck cancers.
Learning Objectives
- Distinguish between appropriate surgical, medical, and radiation therapy options for specific tumor types and disease stages.
- Discuss approaches for improving collaboration among surgical oncology, medical oncology, radiation oncology, radiology, pathology, and supportive-care teams.
- Examine early supportive-care strategies, including speech-language pathology, nutrition, dental oncology, and rehabilitation involvement.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Travel
Airports:
SNA (John Wayne, Santa Ana): 48.5 miles away
LAX (Los Angeles International Airport): 40 miles away
LGB (Long Beach): 36.2 miles away
BUR (Burbank): 29.3 miles away
Public Transportation:
The Los Angeles County's Metro A Line is a light rail system with a conveniently located stop across from the entrance to City of Hope on Duarte Road.
Visit the Metro site for train schedules and fees.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 2.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 2.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
DISCLOSURE INFORMATION:
This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.
As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any ineligible company. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months, that could create a conflict of interest, and an "ineligible company" as any entity producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Any potential conflicts relative to the previous disclosure have been resolved.
Written disclosure of all such relevant financial relationships will be provided in the activity handout and/or syllabus. Any potential conflicts relative to the previous disclosure have been resolved.
City of Hope further encourages faculty/authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.
Available Credit
- 2.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2026 California Head and Neck Cancer Consortium for a maximum of 2.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 2.00 Attendance
Exhibiting/Sponsorship at the 2026 California Head & Neck Cancer Consortium
City of Hope is pleased to offer the opportunity to exhibit and/or sponsor the 2026 California Head & Neck Cancer Consortium, an ACCME accredited consortium focused on enhancing interprofessional collaboration among surgeons, oncologists, radiologists, pathologists, dentists, primary care teams, speech-language pathologists, and supportive care providers. It is the place to highlight the latest advancements in science, technologies and procedures!
Exhibit space & sponsorship is available to companies interested in participating in this consortium.
EXHIBITOR BOOTH/SPONSOR REGISTRATIONS CANNOT BE PROCESSED ONLINE.
Please contact the Department of Continuing Medical Education in order to receive more information, at [email protected].
Acknowledgment of Commercial Support: Any and all grant support will be acknowledged at the symposium via signage and will be listed in the symposium materials.
Price
You must be logged in to your account to complete your registration.
Under "Registrant Type" dropdown (above), select your Registration Fee depending on your profession and click "Add to Cart". Follow the payment prompts.
You will receive an email confirmation once you are registered.
| Registrant Type | Registration Rate |
|---|---|
| Physician | $0 |
| APP/Nurse | $0 |
| Other Allied Health Care Provider | $0 |
| *Industry/Commercial Employee Attendee | $1,200 |
Registration Fee: Registration fee includes all consortium sessions, CME Credit (AMA PRA Category 1 Credit™) for general session if applicable, consortium meals, refreshment breaks and reception**
Cancellation Policy: Refund requests must be submitted in writing and postmarked no later than Friday, May 1, 2026. A $50 processing fee will be applied for all refunds. Requests postmarked after Friday, May 1, 2026, will not be honored. All refunds will be processed 30 days after the meeting concludes. In the event of unforeseeable circumstances that lead to the cancellation by the consortium organizers, all registration fees will be fully refunded.
For questions, contact the Department of Continuing Medical Education at [email protected] or 626-218-5622
*Industry/Commercial Employee Attendee is defined as any individual (regardless of degree) employed by a for-profit entity producing, marketing, selling, re-selling or distributing healthcare products used by or on patients, including biotech, financial, pharmaceutical, etc.
**Registered attendees are invited to attend the Meet the Faculty Reception immediately after the consortium concludes. The reception is included in the cost of registration for registered attendees.